在高度质瘤治疗方面取得了进展
1Department of Radiotherapy, Cancer Center, West China Hospital of Sichuan University, Chengdu, China.
Frontiers in oncology
|April 25, 2024
概括
高度质瘤 (HGG) 治疗的最新进展包括免疫疗法和细胞疗法. 将这些新的方法与传统方法相结合,为HGG患者提供了更好的结果,特别是那些患有复发性瘤的患者.
科学领域:
- 神经瘤学神经瘤学
- 免疫治疗是一种免疫疗法.
- 癌症细胞疗法癌症细胞疗法
背景情况:
- 高度质瘤 (HGG) 由于独特的生物特征和血脑屏障,存在重大治疗挑战.
- 目前HGG的治疗策略包括化疗,放射治疗和向疗法,这些疗法往往被技术进步所增强.
研究的目的:
- 审查高度质瘤 (HGG) 治疗的近期进展.
- 突出免疫疗法和细胞疗法在管理HGG中的作用.
- 讨论新兴的治疗方式和组合策略.
主要方法:
- 关于HGG治疗方式的最新进展的文献综述.
- 专注于免疫治疗 (免疫检查点抑制剂,疫苗,CAR-T细胞) 和细胞疗法.
- 探索新的方法,如瘤治疗领域 (TTFields).
主要成果:
- 免疫疗法,包括免疫检查点抑制剂,疫苗和CAR-T细胞,显示出对复发性HGG的承诺.
- 瘤治疗场 (TTFields) 代表了HGG患者的新兴治疗选择.
- 组合疗法对于改善预后至关重要,特别是对于复发性HGG.
结论:
- 新型免疫疗法和细胞疗法正在扩大高度质瘤的治疗选择.
- 整合包括TTFields在内的多种治疗方式,为提高HGG患者的治疗结果提供了一个有希望的策略.
- 解决HGG复发需要一个多方面的治疗方法.
相关概念视频
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...